Aggressiveness of non-EMT breast cancer cells relies on FBXO11 activity
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt
Standard
Aggressiveness of non-EMT breast cancer cells relies on FBXO11 activity. / Bagger, Sofie Otzen; Hopkinson, Branden Michael; Pandey, Deo Prakash; Bak, Mads; Brydholm, Andreas Vincent; Villadsen, René; Helin, Kristian; Rønnov-Jessen, Lone; Petersen, Ole William; Kim, Jiyoung.
I: Molecular Cancer, Bind 17, Nr. 1, 171, 2018, s. 1-6.Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Aggressiveness of non-EMT breast cancer cells relies on FBXO11 activity
AU - Bagger, Sofie Otzen
AU - Hopkinson, Branden Michael
AU - Pandey, Deo Prakash
AU - Bak, Mads
AU - Brydholm, Andreas Vincent
AU - Villadsen, René
AU - Helin, Kristian
AU - Rønnov-Jessen, Lone
AU - Petersen, Ole William
AU - Kim, Jiyoung
PY - 2018
Y1 - 2018
N2 - Tumorigenesis is increasingly considered to rely on subclones of cells poised to undergo an epithelial to mesenchymal transition (EMT) program. We and others have provided evidence, however, that the tumorigenesis of human breast cancer is not always restricted to typical EMT cells but is also somewhat paradoxically conveyed by subclones of apparently differentiated, non-EMT cells. Here we characterize such non-EMT-like and EMT-like subclones. Through a loss-of-function screen we found that a member of the E3 ubiquitin ligase complexes, FBXO11, specifically fuels tumor formation of a non-EMT-like clone by restraining the p53/p21 pathway. Interestingly, in the related EMT-like clone, FBXO11 operates through the BCL2 pathway with little or no impact on tumorigenesis. These data command caution in attempts to assess tumorigenesis prospectively based on EMT profiling, and they emphasize the importance of next generation subtyping of tumors, that is at the level of clonal composition.
AB - Tumorigenesis is increasingly considered to rely on subclones of cells poised to undergo an epithelial to mesenchymal transition (EMT) program. We and others have provided evidence, however, that the tumorigenesis of human breast cancer is not always restricted to typical EMT cells but is also somewhat paradoxically conveyed by subclones of apparently differentiated, non-EMT cells. Here we characterize such non-EMT-like and EMT-like subclones. Through a loss-of-function screen we found that a member of the E3 ubiquitin ligase complexes, FBXO11, specifically fuels tumor formation of a non-EMT-like clone by restraining the p53/p21 pathway. Interestingly, in the related EMT-like clone, FBXO11 operates through the BCL2 pathway with little or no impact on tumorigenesis. These data command caution in attempts to assess tumorigenesis prospectively based on EMT profiling, and they emphasize the importance of next generation subtyping of tumors, that is at the level of clonal composition.
KW - Breast cancer
KW - shRNA screening
KW - Collective migration
KW - Non-EMT
U2 - 10.1186/s12943-018-0918-6
DO - 10.1186/s12943-018-0918-6
M3 - Comment/debate
C2 - 30526604
VL - 17
SP - 1
EP - 6
JO - Molecular Cancer
JF - Molecular Cancer
SN - 1476-4598
IS - 1
M1 - 171
ER -
ID: 210195701